Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?

PLoS Biol. 2016 Mar 2;14(3):e1002372. doi: 10.1371/journal.pbio.1002372. eCollection 2016 Mar.

Abstract

In the last 15 years, antiretroviral therapy (ART) has been the most globally impactful life-saving development of medical research. Antiretrovirals (ARVs) are used with great success for both the treatment and prevention of HIV infection. Despite these remarkable advances, this epidemic grows relentlessly worldwide. Over 2.1 million new infections occur each year, two-thirds in women and 240,000 in children. The widespread elimination of HIV will require the development of new, more potent prevention tools. Such efforts are imperative on a global scale. However, it must also be recognised that true containment of the epidemic requires the development and widespread implementation of a scientific advancement that has eluded us to date--a highly effective vaccine. Striving for such medical advances is what is required to achieve the end of AIDS.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • AIDS Vaccines
  • Anti-Infective Agents, Local
  • Anti-Retroviral Agents / therapeutic use
  • Antibodies, Neutralizing
  • HIV Infections / prevention & control*
  • Humans
  • Pediatrics

Substances

  • AIDS Vaccines
  • Anti-Infective Agents, Local
  • Anti-Retroviral Agents
  • Antibodies, Neutralizing